Onset varies with age, baseline tissue health, and protocol consistency
You should contact your GP or specialist promptly if you experience any of the following whilst using HGH or any investigational compound: Unexplained changes in blood glucose levels , including symptoms of hypoglycaemia (shakiness, sweating, confusion) or hyperglycaemia (excessive thirst, frequent urination, fatigue) Persistent nausea, vomiting, or abdominal pain , which may indicate gastrointestinal complications Swelling of the hands, feet, or face , which could suggest fluid retention Severe or persistent headache , or any change in vision, which may rarely indicate raised intracranial pressure Injection site reactions , including redness, swelling, or signs of infection Call 999 or attend your nearest A&E immediately if you experience chest pain, severe shortness of breath, palpitations, or any symptoms that could suggest a stroke or severe allergic reaction
a loss of intellectual property protection there could potentially open up a geyser of sophisticated knockoffs
Future MAPP research will validate such phenotypic profiles with longer-term outcomes in this patient population and will identify potential phenotypes based on both biological factors (for example urine biomarker, immune assay, and neuroimaging results) and clinical characteristics